BMS, Van­tAI team up; CRISPR Ther­a­peu­tics to raise $280M; Ono Phar­ma's deal with Shat­tuck Labs

Plus, news about Areteia Ther­a­peu­tics, Su­do Bio­sciences, Cidara Ther­a­peu­tics, Xspray Phar­ma and Sana Biotech­nol­o­gy:

Bris­tol My­ers Squibb inks deal with Van­tAI: The pair plan to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER